At a glance
- Originator Pierre Fabre
- Class Antirheumatics; Carbamates; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders
Most Recent Events
- 04 Nov 1994 Discontinued-I for Rheumatic disorders (Unknown route)